STP Virtual CE Course: Vaccine Development from the Pathologist Perspective W

When:  Aug 28, 2020 from 12:00 PM to 3:30 PM (ET)
Associated with  Student/Resident Corner

Vaccine Development from the Pathologist Perspective

Friday, August 28

Co-Chairs: Rani Sellers, DVM, PhD, DACVP, Pfizer Inc.; and Cynthia Rohde, PhD, Pfizer Inc.

The design and execution of toxicology studies supporting vaccine development have several unique elements relative to the conduct of traditional small molecule- or monoclonal antibody-supporting studies. This course is designed to give an overview of vaccine development, with emphasis on the regulatory guidances and special considerations in vaccine development (prophylactic and therapeutic), study design (including species selection), unique technical considerations, and anatomic and clinical pathology findings.

Introduction to Vaccine Developments
Cynthia M. Rohde, PhD, DABT, Pfizer Inc.

Animal Models to Support Vaccine Development
Rani Sellers, DVM, PhD, DACVP, Pfizer Inc.

Points to Consider in Vaccine Study Design and Implementation
Keith G. Nelson, DVM, PhD, DACVP, Charles River Laboratories

Anatomic and Clinical Pathology Interpretation and Correlations
Niraj K. Tripathi, BVSc, MVSc, PhD, DACVP, Covance; and Bindu Bennet, DVM, MSc, MS, PhD, Voyager Therapeutics

Determining Adversity: Contributions of Local Tolerance, Acute Phase Reactants, and Systemic Reactivity
Panel Presentation

Registration    View More Courses